MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Molecular Pharmacology Fast Forward
First published on August 31, 2005; DOI: 10.1124/mol.105.014829


0026-895X/05/6806-1688-1698$20.00
Mol Pharmacol 68:1688-1698, 2005

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
mol.105.014829v1
68/6/1688    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Walwyn, W.
Right arrow Articles by Hales, T. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Walwyn, W.
Right arrow Articles by Hales, T. G.

Induction of {delta} Opioid Receptor Function by Up-Regulation of Membrane Receptors in Mouse Primary Afferent Neurons

Wendy Walwyn, Nigel T. Maidment, Matthew Sanders, Christopher J. Evans, Brigitte L. Kieffer, and Tim G. Hales

Department of Psychiatry and Biobehavioral Sciences, Center for Health Sciences, University of California, Los Angeles, California (W.W., N.T.M., C.J.E.); Psychology Department, University of California, Los Angeles, Los Angeles, California (M.S.); Institute of Genetics and Molecular and Cellular Biology, Centre National de la Recherche Scientifique/Institut National de la Sante et de la Recherche Medicale/Université Louis Pasteur, Illkirch, France (B.L.K.); and Departments of Pharmacology & Physiology and Anesthesiology & Critical Care Medicine, the George Washington University, Washington, DC (T.G.H.)

It is not clear whether primary afferent neurons express functional cell-surface {delta} opioid receptors. We examined {delta} receptor coupling to Ca2+ channels in mouse dorsal root ganglion neurons under basal conditions and after {delta} receptor up-regulation. [D-Ala2,Phe4,Gly5-ol]-enkephalin (DAMGO), [D-Ala2,D-Leu5]-enkephalin (DADLE), trans-(±)-3,4-dichloro-N-methyl-N-(2-[1-pyrrolidinyl]cyclohexyl) benzene-acetamide methanesulfonate (U-50,488H; 1 µM), and baclofen (50 µM) inhibited Ca2+ currents, whereas the {delta}-selective ligands [D-Pen2,Pen5]-enkephalin (DPDPE) and deltorphin II (1 µM) did not. The effect of DADLE (1 µM) was blocked by the µ-antagonist D-Phe-Cys-Tyr-D-Trp-Arg-Thr-Pen-Thr-NH2 (CTAP; 300 nM) but not by the {delta}-antagonist Tyr-1,2,3,4-tetrahydroisoquinoline-Phe-Phe-OH (300 nM), implicating µ receptors. Despite a lack of functional {delta} receptors, flow cytometry revealed cell-surface {delta} receptors. We used this approach to identify conditions that up-regulate {delta} receptors, including µ receptor gene deletion in dorsal root ganglion neurons of µ-/- mice and 18-h incubation of µ+/+ neurons with CTAP followed by brief (10-min) DPDPE exposure. Under these conditions, the expression of cell-surface {delta} receptors was up-regulated to 149 ± 9 and 139 ± 5%, respectively; furthermore, DPDPE and deltorphin II (1 µM) inhibited Ca2+ currents in both cases. Viral replacement of µ receptors in µ-/- neurons reduced {delta} receptor expression to µ+/+ levels, restored the inhibition of Ca2+ currents by DAMGO, and abolished {delta} receptor coupling. Our observations suggest that {delta} receptor-Ca2+ channel coupling in primary afferent fibers may have little functional significance under basal conditions in which µ receptors predominate. However, up-regulation of cell-surface {delta} receptors induces their coupling to Ca2+ channels. Pharmacological approaches that increase functional {delta} receptor expression may reveal a novel target for analgesic therapy.


Received May 13, 2005; accepted August 31, 2005

Address correspondence to: Dr. Tim G. Hales, Department of Pharmacology and Physiology, Medical Center, The George Washington University, 2300 Eye Street NW, Washington, DC 20037. E-mail: phmtgh{at}gwumc.edu.




This article has been cited by other articles:


Home page
Proc. Natl. Acad. Sci. USAHome page
F. M. Decaillot, R. Rozenfeld, A. Gupta, and L. A. Devi
Cell surface targeting of {micro}-{delta} opioid receptor heterodimers by RTP4
PNAS, October 14, 2008; 105(41): 16045 - 16050.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
W. Walwyn, C. J. Evans, and T. G. Hales
{beta}-Arrestin2 and c-Src Regulate the Constitutive Activity and Recycling of {micro} Opioid Receptors in Dorsal Root Ganglion Neurons
J. Neurosci., May 9, 2007; 27(19): 5092 - 5104.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
G. Scherrer, P. Tryoen-Toth, D. Filliol, A. Matifas, D. Laustriat, Y. Q. Cao, A. I. Basbaum, A. Dierich, J.-L. Vonesh, C. Gaveriaux-Ruff, et al.
Knockin mice expressing fluorescent {delta}-opioid receptors uncover G protein-coupled receptor dynamics in vivo
PNAS, June 20, 2006; 103(25): 9691 - 9696.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2005 by the American Society for Pharmacology and Experimental Therapeutics